Dr. Young is the C.E.O., C.S.O., and co-founder of KisoJi. Previously, he was the founder, C.S.O. and C.E.O. of ARIUS Research Inc., a publicly-traded biotechnology company developing therapeutic cancer antibodies and sold to Roche in 2008. ARIUS had secured partnerships with leading companies such as Genentech, Takeda Pharmaceuticals, and Protein Design Labs.
He is the inventor or author on over 200 patents and scientific papers. He is a recognized entrepreneur and has served on many non-profit boards. He is founding Chairman of the Ontario Biosciences Innovation Organization, a non-profit biotech industry group.
Dr. Young received his M.D., his M.Sc. and did his surgical and science training in the General Surgery and the Surgeon Scientist Program, all at the University of Toronto.
He is the inventor or author on over 200 patents and scientific papers. He is a recognized entrepreneur and has served on many non-profit boards. He is founding Chairman of the Ontario Biosciences Innovation Organization, a non-profit biotech industry group.
Dr. Young received his M.D., his M.Sc. and did his surgical and science training in the General Surgery and the Surgeon Scientist Program, all at the University of Toronto.
Speaking In
[Available On-Demand]
KisoJi is a next-generation antibody company developing multi-specific antibodies to improve…
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
